Shares in Natco Rally On Hepatitis Approval

Subscribe to GoodReturns
For Quick Alerts
Subscribe Now  
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    Shares in Natco rallied after the company received an approval for generic Hepatitis C medicine. The stock was up over 5 per cent at Rs 1,963 on the National Stock Exchange.

    Shares in Natco Rally On Hepatitis Approval
    Natco Pharma: Quotes, News
    BSE 726.55BSE Quote6.1 (0.84%)
    NSE 726.75NSE Quote9.35 (1.29%)
    It also hit a new 52-week high of Rs 1984 in intra day trading.

    "Natco Pharma is pleased to announce that it is the 1st company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India)," the company said in a press release.

    GoodReturns.in

    Read more about: natco
    Story first published: Thursday, March 12, 2015, 12:20 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'
    India's LARGEST EVER political poll. Have you participated yet?

    Find IFSC

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more